Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. LVRO
LVRO logo

LVRO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
627.35M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
241.99M
EV/OCF(TTM)
--
P/S(TTM)
0.03
Lavoro Limited is a Brazil-based agricultural input retailer and a provider of agriculture biologics inputs. The Company has three reportable segments: the Brazil Cluster, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; the LATAM Cluster, which includes companies dedicated to the distribution ofagricultural inputs outside Brazil primarily in Colombia; as well as the Crop Care Cluster, which includes companies that produce and import Lavoro's own portfolio of private label products including off-patent crop protection and specialty products, e.g., biologicals and specialty fertilizers. The main crops served are: soy, corn, cotton, coffee, beans, rice, sugar cane, wheat, citrus and pastures. The Company has a broad geographical presence, operating in Brazil, Colombia, and Uruguay.
Show More

Events Timeline

(ET)
2026-02-13
17:10:00
Lavoro Announces Voluntary Delisting from Nasdaq
select
2025-11-24 (ET)
2025-11-24
16:37:48
Lavoro Issued Noncompliance Notice by Nasdaq
select
2025-07-14 (ET)
2025-07-14
16:12:25
Lavoro receives noncompliance notification from Nasdaq
select

News

Newsfilter
8.5
02-13Newsfilter
Lavoro Announces Voluntary Delisting from Nasdaq
  • Voluntary Delisting Decision: Lavoro Limited has announced its intention to voluntarily delist its ordinary shares and warrants, with a Form 25 filing expected on February 24, 2026, reflecting the company's operational challenges and cost pressures amid a difficult market environment in Brazil.
  • Liquidity Issues: The company's low trading volume and limited public shareholder base have severely impacted the liquidity of its securities, restricting its ability to access U.S. capital markets and making it difficult to attract interest from institutional investors and market analysts.
  • High Compliance Costs: Lavoro continues to incur significant audit, legal, and compliance costs associated with being a publicly traded company, particularly under the Sarbanes-Oxley Act, leading to an operational burden that outweighs the potential benefits of maintaining a public listing.
  • Change in Trading Methods: Following the delisting, trading of Lavoro's ordinary shares and warrants will only occur through privately negotiated sales or potentially on an over-the-counter market, with no guarantee that a broker will provide a market, which may further affect investor liquidity and trading opportunities.
Benzinga
9.0
01-05Benzinga
GH Research Plc Receives FDA Lift on Clinical Hold, Stock Rises 34.5%
  • FDA Approval: The U.S. Food and Drug Administration (FDA) lifted the clinical hold on GH Research Plc's (NASDAQ:GHRS) Investigational New Drug Application (IND) on Monday, enabling the company to proceed with its clinical trials, which is expected to accelerate product development and enhance market competitiveness.
  • Positive Market Reaction: Following the announcement, GH Research's stock surged 34.5% to $17.80, reflecting investor optimism about the company's future potential and likely attracting more investor interest in its subsequent developments.
  • Industry Impact: This FDA approval not only brings direct capital inflow to GH Research but may also encourage other biotech firms to expedite their clinical trial processes, thereby fostering innovation and growth across the industry.
  • Increased Investor Confidence: With the clinical hold lifted, GH Research is poised to accelerate its product launch timeline in the coming months, further boosting investor confidence and enhancing the company's market position in the biopharmaceutical sector.
Benzinga
5.0
01-05Benzinga
GH Research PLC Shares Surge 18.1% on FDA IND Status Update Announcement
  • Significant Stock Surge: GH Research PLC shares rose 18.1% to $15.64 in pre-market trading, reflecting strong market anticipation for the upcoming update on its FDA IND status and Phase 3 program for GH001, which could pave the way for future drug approvals.
  • Positive Market Reaction: As the company prepares to update its treatment plan for treatment-resistant depression, investor confidence in GH Research's prospects has significantly increased, potentially attracting more investors and enhancing the company's market valuation.
  • Industry-Wide Impact: The progress of GH Research may not only boost its own stock price but also positively influence the entire biopharmaceutical sector, particularly in the treatment-resistant depression space, encouraging other companies to increase their R&D investments.
  • Optimistic Future Outlook: With the FDA update on the horizon, GH Research is poised to gather more clinical data in the coming months, which will provide crucial support for its subsequent marketing and commercialization strategies, strengthening its position in the competitive pharmaceutical market.
Benzinga
8.5
01-02Benzinga
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
  • Capital Raising Announcement: Intelligent Bio Solutions revealed plans to raise $10 million through a private placement, which led to a sharp 19.7% decline in its stock price during Friday's session, indicating a negative impact on investor confidence and market performance.
  • Stock Price Reaction: Following the announcement, shares of Intelligent Bio fell to $7.65, reflecting market concerns regarding the company's future financial health and potentially affecting its ability to secure further funding.
  • Market Dynamics: While Intelligent Bio's stock plummeted, other stocks such as Lavoro Limited and Ironwood Pharmaceuticals surged by 181% and 57.7% respectively, highlighting a divergence in market performance among different companies.
  • Investor Focus: The announcement of this capital raising plan may prompt investors to reassess Intelligent Bio's strategic direction, particularly in the current market environment where the necessity and timing of fundraising are critically important.
Benzinga
7.5
2025-09-17Benzinga
New Fortress Energy Shares Surge 41%; Check Out 20 Stocks Making Moves in Premarket Trading
  • New Fortress Energy Agreement: New Fortress Energy Inc. shares surged 41% in pre-market trading after announcing a long-term liquefied natural gas supply agreement with the Puerto Rican government.

  • Pre-Market Stock Movements: Several stocks experienced significant pre-market trading changes, with SciSparc Ltd. gaining 186.2% and Co-Diagnostics, Inc. dropping 29.2% following recent developments.

Benzinga
7.5
2025-09-16Benzinga
Webtoon Entertainment Shares Surge 48%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Webtoon Entertainment Partnership: Webtoon Entertainment Inc's shares surged 47.8% in pre-market trading after announcing a partnership with The Walt Disney Co to create a digital comics platform featuring Marvel, Star Wars, Pixar, and Disney titles.

  • Pre-Market Stock Movements: Several stocks experienced significant pre-market trading changes, with FGI Industries Ltd gaining 185.2% and Conifer Holdings Inc rising 136.8%, while Apartment Investment and Management Company saw a decline of 9.4%.

Valuation Metrics

The current forward P/E ratio for Lavoro Ltd (LVRO.O) is -1.30, compared to its 5-year average forward P/E of -0.41. For a more detailed relative valuation and DCF analysis to assess Lavoro Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.41
Current PE
-1.30
Overvalued PE
32.00
Undervalued PE
-32.81

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
7.97
Current EV/EBITDA
9.64
Overvalued EV/EBITDA
13.35
Undervalued EV/EBITDA
2.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.24
Current PS
0.10
Overvalued PS
0.52
Undervalued PS
-0.05

Financials

AI Analysis
Annual
Quarterly

Whales Holding LVRO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Lavoro Ltd (LVRO) stock price today?

The current price of LVRO is 0 USD — it has decreased -32.24

What is Lavoro Ltd (LVRO)'s business?

Lavoro Limited is a Brazil-based agricultural input retailer and a provider of agriculture biologics inputs. The Company has three reportable segments: the Brazil Cluster, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; the LATAM Cluster, which includes companies dedicated to the distribution ofagricultural inputs outside Brazil primarily in Colombia; as well as the Crop Care Cluster, which includes companies that produce and import Lavoro's own portfolio of private label products including off-patent crop protection and specialty products, e.g., biologicals and specialty fertilizers. The main crops served are: soy, corn, cotton, coffee, beans, rice, sugar cane, wheat, citrus and pastures. The Company has a broad geographical presence, operating in Brazil, Colombia, and Uruguay.

What is the price predicton of LVRO Stock?

Wall Street analysts forecast LVRO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LVRO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Lavoro Ltd (LVRO)'s revenue for the last quarter?

Lavoro Ltd revenue for the last quarter amounts to 2.05B USD, decreased -13.24

What is Lavoro Ltd (LVRO)'s earnings per share (EPS) for the last quarter?

Lavoro Ltd. EPS for the last quarter amounts to -2.19 USD, increased 271.19

How many employees does Lavoro Ltd (LVRO). have?

Lavoro Ltd (LVRO) has 2975 emplpoyees as of March 11 2026.

What is Lavoro Ltd (LVRO) market cap?

Today LVRO has the market capitalization of 627.35M USD.